2015 Press Releases

Page 5 of 5

• 7/8/2015 AG Jepsen: Joint State-Federal Settlement with Chase Will Reform Credit Card Debt Collection Practices, Cease Collection Actions on 5,000 Connecticut Consumer Accounts

  Connecticut has joined with 46 other states, the District of Columbia and the federal Consumer Financial Protection Bureau in a $136 million settlement with Chase Bank USA N.A. and Chase Bankcard Services, Inc. to resolve allegations that the bank engaged in unfair, misleading and deceptive business practices – including so-called "robosigning" – in connection with its consumer credit card debt collection business, Attorney General George Jepsen announced today.

• 3/10/2015 Attorney General Jepsen Joins Coalition in Widening Probe of Herbal Supplement Industry

  Attorney General George Jepsen today announced that he has joined a coalition of state attorneys general to examine labeling, quality control and other aspects of the herbal supplement industry.

• 3/10/2015 Attorney General Jepsen Wants Information from Lumber Liquidators on Formaldehyde Levels in Some Laminate Flooring Products

  Attorney General George Jepsen wants information from flooring retailer Lumber Liquidators about Chinese-manufactured laminate flooring sold online and in its Connecticut stores that, according to a recent media report, may contain high levels of formaldehyde despite purporting to be in compliance with certain legal standards.

• 11/9/2015 State Joins National Settlement with AstraZeneca Pharmaceuticals, LP and Cephalon, Inc. to Resolve Overcharging Allegations

  Attorney General George Jepsen, Chief State’s Attorney Kevin T. Kane and state Department of Social Services (DSS) Commissioner Roderick L. Bremby announced today that Connecticut has joined a federal-state settlement with AstraZeneca Pharmaceuticals, LP and Cephalon, Inc. to resolve allegations that the companies inappropriately overcharged state Medicaid programs for drugs. AstraZeneca, a London and Delaware-based pharmaceutical manufacturer, has paid the states and the federal government $46.5 million to resolve allegations against the company. Cephalon, a Pennsylvania-based subsidiary of Teva Pharmaceuticals Industries, Ltd., has paid the states and the federal government $7.5 million to settle similar allegations.

• 6/2/2015 Statement from AG Jepsen on Final Passage of Data Breach Notification and Consumer Protection Legislation

  "My office will continue to aggressively investigate these breaches and, where appropriate, take action when we feel that notification has not been reasonable or protections offered to consumers are not adequate."